Test of Two Taxanes Shows Clear Winner in Breast Cancer

Share this content:
Test of Two Taxanes Shows Clear Winner in Breast Cancer
Test of Two Taxanes Shows Clear Winner in Breast Cancer
A comparison of two paclitaxels resulted in a clear win for nab-paclitaxel (Abraxane) as neoadjuvant therapy for early breast cancer, a large randomized trial showed. Treatment with nab (nanoparticle albumin-bound)-paclitaxel resulted in a pathologic complete response (pCR) of 38% compared with 29% for solvent-based paclitaxel.
READ FULL ARTICLE From Medical Page Today
Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease



Sign up for myCME e-newsletters




is free, fast, and customized just for you!




Already a member?

Sign In Now »